Project Grant K01DA063748
Award Date 8/15/25
Completion Date 7/31/30
Dollars Obligated $208K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
- This Project Grant award of $107,912 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a mixed methods study to better understand prenatal polysubstance use in the United States. The research involves two components: 1) Conducting 20 qualitative interviews with pregnant or postpartum individuals engaged in polysubstance use to explore the biopsychosocial context of these behaviors, and 2) Utilizing the CDC Pregnancy...
- This Project Grant award of $840,425.00 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, under the Drug Use and Addiction Research Programs (CFDA 93.279). The funding will support research examining the impact of pre- and postnatal substance exposure, maternal distress, and related parent-child interpersonal processes on the development of adolescent risk behaviors, including substance use and delinquency. The research will leverage a...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $1,445,752 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to New York University School of Medicine. The grant, titled "Characterizing Complex OUD Care Trajectories and Outcomes Following Acute Service Utilization: A Population-Based Data Linkage Study," aims to apply novel research approaches to better understand real-world opioid use disorder (OUD)...
- This $6,439,263 federal Project Grant awarded by the National Institute on Drug Abuse (CFDA 93.279 Drug Abuse and Addiction Research Programs) aims to determine the impact of maternal substance use on maternal immune activation, placental function, and offspring neurobehavioral development. The project will leverage the Healthy Brain and Child Development (HBCD) study to perform maternal immune profiling, placental and cord blood analysis, and novel neuroinflammation imaging on 400 pregnancies...
- The National Institute on Drug Abuse (NIDA) awarded The Washington University a 3-year, $2,337,729 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to study the impact of prenatal opioid exposure on placental and fetal brain development. The project, titled "The Opioid in Pregnancy: Imaging of Oxygenation, Inflammation, and Development in Brain & Placenta" (OPIOID BPP), aims to define the longitudinal effects of prenatal opioid exposure on...
- The National Institutes of Health (NIH) awarded Boston Medical Center Corporation a $2,573,346 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The 3-year grant, which commenced on September 1, 2023, will fund a prospective cohort study comparing 100 opioid-exposed pregnancies to 50 non-exposed controls. The study aims to: Compare serial microRNA (miRNA) signatures in opioid-exposed and control pregnancies using maternal plasma and placental tissue samples. The...
- This federal Project Grant award of $196,236.00, provided by the National Institute on Drug Abuse (CFDA 93.279 Drug Use and Addiction Research Programs), aims to investigate the mechanisms contributing to preconceptions about those who use cannabis, especially during pregnancy, and the impact on the quality of prenatal care. The key objectives of the 5-year project (July 2025 - June 2030) are to: (1) investigate preconceptions about cannabis use during pregnancy using a mixed-methods approach...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $192,500 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Wayne State University. The grant supports a 2-year study to measure the effects of gestational fentanyl exposure on offspring in a rodent model. The research aims to determine the impact on morbidity, mortality, developmental milestones, external morphology, blood cholesterol, brain morphology and...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a study to develop novel methods for estimating the prevalence of drug use among older adults in New York City. The $960,696 award to New York University will administer a rapid drug survey and conduct saliva and hair testing on 300 adults aged 65+ to determine the extent to which biological testing adds to self-reported drug use data. The...
- This Project Grant award of $761,367, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to determine whether biomarkers in fetal central nervous system-derived extracellular vesicles can predict derangements in fetal neurodevelopment in women using cannabinoids during pregnancy. The 5-year project, which began on September 1, 2025, will partner with an ongoing NIH-funded clinical cohort of 450 subjects to identify novel...